CCM
ETTX

CAAS Capital Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

CAAS Capital Management’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-579,379
Closed -$1.18M – 962
2020
Q3 		$1.18M Buy
+579,379
New +$1.65M 0.03% 318

Other funds holding ETTX

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

CAAS Capital Management's ETTX Position: Q4 2020 in Review

CAAS Capital Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 579,379 shares — an estimated $1.18M sold.

CAAS Capital Management first reported a position in ETTX in Q3 2020 and held it in 1 quarter. The position peaked at $1.18M in Q3 2020. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

  • CAAS Capital Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
  • CAAS Capital Management sold 579,379 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $1.18M.
  • CAAS Capital Management first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2020 and held it in 1 quarter.
  • CAAS Capital Management's Entasis Therapeutics Holdings Inc. position peaked at $1.18M in Q3 2020.
  • 25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.